Investments
1234Portfolio Exits
115Funds
9Partners & Customers
10About Bpifrance
Bpifrance (Banque Publique d'Investissement) assists companies by booting up their listing on the stock exchange and offering credit to equity. BPI France provides companies a continuum of funding at every stage of their development.
Bpifrance Headquarter Location
27-31 Avenue du General Leclerc
Maisons-Alfort, 94710,
France
Expert Collections containing Bpifrance
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Bpifrance in 1 Expert Collection, including Sovereign Wealth Funds.
Sovereign Wealth Funds
22 items
The world's most active sovereign wealth funds investing in private tech companies.
Research containing Bpifrance
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Bpifrance in 3 CB Insights research briefs, most recently on Aug 5, 2021.
Aug 5, 2021
Here Are The Most Active Healthcare InvestorsAug 4, 2020
Here Are Q2’s Most Active Healthcare InvestorsLatest Bpifrance News
Jun 24, 2022
Nantes, FRANCE Saint-Herblain (France), June 24, 2022 – Valneva S E (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Management Board were approved by the shareholders at its Annual General Meeting (AGM) held yesterday in Paris. Among the adopted resolutions were approval of the 2021 financial statements, delegations for the management board to increase Valneva’s share capital and/or issue financial instruments, and the appointment, for a three-year term, of two new Supervisory Board members. Bpifrance Participations was appointed to Valneva’s Supervisor Board and will be represented by Maïlys Ferrère. Ms. Ferrère, a French national, is Director of Large Venture Investments at Bpifrance, France’s state-owned investment bank. In her role at Bpifrance, she sits on various boards of Euronext-listed companies. Before joining Bpifrance Large Venture in 2013, Ms. Ferrère was an Investment Director at the Fonds Stratégique d’Investissement. Prior to this, Ms. Ferrère had a career in the banking industry, focusing on equity capital markets in various financial institutions. She graduated from Institut d’Etudes Politiques de Paris. James Edward Connolly, an American national, was also appointed to Valneva’s Supervisory Board. Mr. Connolly is a seasoned business executive with more than three decades of experience in the life sciences industry. Since 2013, Mr. Connolly has been serving on a number of boards for a variety of vaccine, biopharmaceutical and investment organizations. From 2010 to 2013, Mr. Connolly was President and CEO of Aeras (now IAVI.) Prior to this, he had a long and successful 24-year career at Wyeth (now Pfizer), where he held a series of senior roles, the last two of which were Executive Vice President and General Manager, Wyeth Vaccines and President, Wyeth Canada. During his tenure leading Wyeth Vaccines, Mr. Connolly played a leading role building the company’s vaccines business into one of the top four global manufacturers and creating the first true blockbuster vaccine, Prevnar, with sales in excess of $3 billion. Additionally, the term of office of Supervisory Board members Frédéric Grimaud, James Sulat, and Anne-Marie Graffin was renewed until June 2025. In a separate meeting, Frédéric Grimaud was re-elected as Chairman of Valneva’s Supervisory Board. Valneva also confirmed during the AGM that initiation of the Phase 3 study of Lyme disease vaccine candidate VLA15 is planned in the third quarter of 2022 and that it is expecting to submit the Biologics License Application (BLA) for its chikungunya vaccine candidate VLA1553 to the Food and Drug Administration (FDA) in the second half of 2022. The AGM’s voting results will be made available in the “ Investors & Media ” section of Valneva’s corporate website in the coming days. About Valneva SE Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company takes a highly specialized and targeted approach to vaccine development and then applies its deep understanding of vaccine science to develop prophylactic vaccines addressing these diseases. Valneva has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19. Media & Investor Contacts
Bpifrance Investments
1,234 Investments
Bpifrance has made 1,234 investments. Their latest investment was in Arterya as part of their Seed on June 6, 2022.
Bpifrance Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
6/24/2022 | Seed | Arterya | $1.06M | Yes | 1 | |
6/24/2022 | Seed | Conformitee | $1.58M | Yes | 1 | |
6/23/2022 | Grant - III | Osivax | $10.52M | No | 1 | |
6/23/2022 | Seed VC | |||||
6/21/2022 | Series A |
Date | 6/24/2022 | 6/24/2022 | 6/23/2022 | 6/23/2022 | 6/21/2022 |
---|---|---|---|---|---|
Round | Seed | Seed | Grant - III | Seed VC | Series A |
Company | Arterya | Conformitee | Osivax | ||
Amount | $1.06M | $1.58M | $10.52M | ||
New? | Yes | Yes | No | ||
Co-Investors | |||||
Sources | 1 | 1 | 1 |
Bpifrance Portfolio Exits
115 Portfolio Exits
Bpifrance has 115 portfolio exits. Their latest portfolio exit was Rapidle on June 23, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
6/23/2022 | Acquired | 1 | |||
6/7/2022 | Acquired | 1 | |||
6/2/2022 | Asset Sale | 2 | |||
Date | 6/23/2022 | 6/7/2022 | 6/2/2022 | ||
---|---|---|---|---|---|
Exit | Acquired | Acquired | Asset Sale | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 1 | 1 | 2 |
Bpifrance Acquisitions
46 Acquisitions
Bpifrance acquired 46 companies. Their latest acquisition was LV Overseas on January 31, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
1/31/2022 | Acq - Fin - II | 1 | ||||
7/22/2021 | Acq - Fin | 3 | ||||
12/17/2020 | Acq - Fin | 1 | ||||
11/27/2020 | ||||||
3/12/2020 | Other Venture Capital |
Date | 1/31/2022 | 7/22/2021 | 12/17/2020 | 11/27/2020 | 3/12/2020 |
---|---|---|---|---|---|
Investment Stage | Other Venture Capital | ||||
Companies | |||||
Valuation | |||||
Total Funding | |||||
Note | Acq - Fin - II | Acq - Fin | Acq - Fin | ||
Sources | 1 | 3 | 1 |
Bpifrance Fund History
9 Fund Histories
Bpifrance has 9 funds, including Bpifrance Hexagone 1 FPCI.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
9/4/2020 | Bpifrance Hexagone 1 FPCI | $49.24M | 1 | ||
5/25/2020 | LAC 1 | ||||
12/4/2017 | Digital Health Fund | ||||
11/20/2017 | Defense Investment Vehicle | ||||
9/14/2016 | BPI France SME Fund |
Closing Date | 9/4/2020 | 5/25/2020 | 12/4/2017 | 11/20/2017 | 9/14/2016 |
---|---|---|---|---|---|
Fund | Bpifrance Hexagone 1 FPCI | LAC 1 | Digital Health Fund | Defense Investment Vehicle | BPI France SME Fund |
Fund Type | |||||
Status | |||||
Amount | $49.24M | ||||
Sources | 1 |
Bpifrance Partners & Customers
10 Partners and customers
Bpifrance has 10 strategic partners and customers. Bpifrance recently partnered with Mubadala on December 12, 2021.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
12/5/2021 | Partner | United Arab Emirates | Mubadala inks $6.11bn deals to invest in French priority sectors Nicolas Dufourcq , CEO of Bpifrance , stated : `` We are proud of this major step forward in our partnership with Mubadala Investment Company , which was initiated in 2014 . | 1 | |
12/4/2021 | Partner | United Arab Emirates | Mubadala signs two agreements to facilitate investments in priority sectors in France Existing co-investment partnerships between Mubadala Investment Company and Bpifrance is extended with an additional € 4 billion joint commitment . | 2 | |
6/30/2021 | Partner | United Arab Emirates | BpiFrance and Mubadala form African Private Equity Platform Bpifrance and Mubadala Investment Company have worked together since the launch of the French Emirati Fund in 2014 and the Innovation Partnership in 2017 , with approximately EUR 1 billion of joint investments in French companies , and a EUR 1 billion commitment by Mubadala Investment Company into Bpifrance 's flagship Lac1 Fund dedicated to listed French multinationals . | 1 | |
2/2/2021 | Partner | ||||
11/4/2020 | Partner |
Date | 12/5/2021 | 12/4/2021 | 6/30/2021 | 2/2/2021 | 11/4/2020 |
---|---|---|---|---|---|
Type | Partner | Partner | Partner | Partner | Partner |
Business Partner | |||||
Country | United Arab Emirates | United Arab Emirates | United Arab Emirates | ||
News Snippet | Mubadala inks $6.11bn deals to invest in French priority sectors Nicolas Dufourcq , CEO of Bpifrance , stated : `` We are proud of this major step forward in our partnership with Mubadala Investment Company , which was initiated in 2014 . | Mubadala signs two agreements to facilitate investments in priority sectors in France Existing co-investment partnerships between Mubadala Investment Company and Bpifrance is extended with an additional € 4 billion joint commitment . | BpiFrance and Mubadala form African Private Equity Platform Bpifrance and Mubadala Investment Company have worked together since the launch of the French Emirati Fund in 2014 and the Innovation Partnership in 2017 , with approximately EUR 1 billion of joint investments in French companies , and a EUR 1 billion commitment by Mubadala Investment Company into Bpifrance 's flagship Lac1 Fund dedicated to listed French multinationals . | ||
Sources | 1 | 2 | 1 |
Bpifrance Team
8 Team Members
Bpifrance has 8 team members, including current Managing Director, Luc Heinrich.
Name | Work History | Title | Status |
---|---|---|---|
Luc Heinrich | CDC Entreprises, Alcatel-Lucent, McKinsey & Company, Bottin, and Orange | Managing Director | Current |
Menele Chesnot | Active Assurances, Eductive, ADIT, FSI Regions, and Fiducial | Senior Director | Current |
Romain Fourcade | Aviva, and iXO Private Equity | Senior Director | Current |
Chahra Louafi | CDC Entreprises | Senior Director | Current |
Olivier Martinez | CDC Entreprises, and Bioam Gestion | Senior Director | Current |
Name | Luc Heinrich | Menele Chesnot | Romain Fourcade | Chahra Louafi | Olivier Martinez |
---|---|---|---|---|---|
Work History | CDC Entreprises, Alcatel-Lucent, McKinsey & Company, Bottin, and Orange | Active Assurances, Eductive, ADIT, FSI Regions, and Fiducial | Aviva, and iXO Private Equity | CDC Entreprises | CDC Entreprises, and Bioam Gestion |
Title | Managing Director | Senior Director | Senior Director | Senior Director | Senior Director |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.